SENS (Senseonics Holdings) Cash Ratio: 5.78 (As of Jun. 2026) — 51% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SENS Senseonics Holdings Inc SENS
56 GF Score
Price $8.82
GF Value $12.51
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Senseonics Holdings Cash Ratio?

Senseonics Holdings SENS -3.18% 56 Cash Ratio is 5.78 as of Jun. 2026, which is 51% above its 10-year median of 3.82. GuruFocus rates SENS with a GF Score™ of 56/100 and a GF Value™ of $12.51 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 825 Medical Devices & Instruments companies, Senseonics Holdings ranks better than 89.33% on this metric.

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Senseonics Holdings's Cash Ratio for the quarter that ended in Jun. 2026 was 5.78.

Senseonics Holdings has a Cash Ratio of 5.78. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Senseonics Holdings's Cash Ratio or its related term are showing as below:

SENS' s Cash Ratio Range Over the Past 10 Years
Min: 0.76   Med: 3.82   Max: 11.39
Current: 5.78

During the past 12 years, Senseonics Holdings's highest Cash Ratio was 11.39. The lowest was 0.76. And the median was 3.82.

SENS's Cash Ratio is ranked better than
89.33% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 0.95 vs SENS: 5.78

Senseonics Holdings  (NAS:SENS) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Senseonics Holdings Cash Ratio Related Terms


Senseonics Holdings Cash Ratio Historical Data

* Premium members only.

The historical data trend for Senseonics Holdings's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senseonics Holdings Cash Ratio Chart

Senseonics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.06 4.58 6.34 1.92 3.86

Senseonics Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.56 5.26 3.86 2.44 5.78

SENS vs TLSI, TMCI, SGHT: Cash Ratio Comparison

For the Medical Devices subindustry, Senseonics Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senseonics Holdings Cash Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Senseonics Holdings's Cash Ratio falls into.


SENS
56GF Score
Senseonics Holdings Inc SENS
Cash Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senseonics Holdings Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Senseonics Holdings's Cash Ratio for the fiscal year that ended in Dec. 2025 is calculated as:

Cash Ratio (A: Dec. 2025 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=94.03/24.348
=3.86

Senseonics Holdings's Cash Ratio for the quarter that ended in Jun. 2026 is calculated as:

Cash Ratio (Q: Jun. 2026 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=142.659/24.679
=5.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Ratio →
What does a Cash Ratio of 5.78 mean?
Senseonics Holdings (SENS) has a Cash Ratio of 5.78 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Senseonics Holdings and its competitors. This is 51% above median its historical median of 3.82. Over the past decade, Senseonics Holdings' Cash Ratio has ranged from 0.76 to 11.39. According to the industry distribution chart, Senseonics Holdings ranks #88 out of 825 companies in the Medical Devices & Instruments industry, placing it in the top 10.7%.
Is Senseonics Holdings' Cash Ratio too high?
Senseonics Holdings' current Cash Ratio of 5.78 is 51% above median its 10-year median of 3.82. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 11.39. The Medical Devices & Instruments industry median Cash Ratio is 0.95. Senseonics Holdings' value of 5.78 is 508.4% above this industry median. Based on the distribution chart, Senseonics Holdings ranks #88 out of 825 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Senseonics Holdings has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' Cash Ratio compare to TLSI and TMCI?
According to the Medical Devices & Instruments industry distribution chart, Senseonics Holdings ranks #88 out of 825 companies for Cash Ratio. This places Senseonics Holdings in the top 11% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.95. Senseonics Holdings' value of 5.78 is 508.4% above this benchmark. Historically, Senseonics Holdings' own Cash Ratio has ranged from 0.76 to 11.39 over the past decade. While the company's 10-year median is 3.82 vs. the industry median of 0.95, Senseonics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.95, based on 825 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senseonics Holdings's current Cash Ratio of 5.78 is 508.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Senseonics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senseonics Holdings's current Cash Ratio is 5.78, which is 51% above median its own 10-year median of 3.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Modestly Undervalued. The stock's GF Value™ is $12.51, compared to a current price of $8.82 — trading 29.5% below its estimated fair value. The current Cash Ratio is 5.78, which is 51% above median its 10-year median of 3.82 and 508.4% above the Medical Devices & Instruments industry median of 0.95. Senseonics Holdings' overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current Cash Ratio is 5.78 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Senseonics Holdings (SENS) Overvalued in 2026?

Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued. The current stock price of $8.82 is trading 29.5% below its estimated GF Value™ of $12.51. GuruFocus considers Senseonics Holdings to be Modestly Undervalued.

Key valuation signals for SENS:

  • Cash Ratio: 5.78 (51% above median its 10-year median of 3.82)
  • GF Value™: $12.51 vs. price of $8.82 (29.5% below fair value)
  • GF Score™: 56/100 with 5 warning signs
  • Industry Position: 508.4% above the Medical Devices & Instruments median (#88 of 825)

No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Senseonics Holdings Business Description

Other Exchanges 6L60:Germany
Address 20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
56GF Score

Get the complete analysis for SENS

Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.82
Price
$12.51
GF Value